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AbsTrACT
Objective We adapted a composite neonatal adverse 
outcome indicator (NAOI), originally derived in Australia, 
and assessed its feasibility and validity as an outcome 
indicator in English administrative hospital data.
Design We used Hospital Episode Statistics (HES) 
data containing information infants born in the English 
National Health Service (NHS) between 1 April 2014 
and 31 March 2015. The Australian NAOI was mapped 
to diagnoses and procedure codes used within HES and 
modified to reflect data quality and neonatal health 
concerns in England. To investigate the concurrent 
validity of the English NAOI (E-NAOI), rates of NAOI 
components were compared with population-based 
studies. To investigate the predictive validity of the 
E-NAOI, rates of readmission and death in the first year 
of life were calculated for infants with and without 
E-NAOI components.
results The analysis included 484 007 (81%) of the 
600 963 eligible babies born during the timeframe. 
114/148 NHS trusts passed data quality checks and were 
included in the analysis. The modified E-NAOI included 
23 components (16 diagnoses and 7 procedures). 
Among liveborn infants, 5.4% had at least one E-NAOI 
component recorded before discharge. Among newborns 
discharged alive, the E-NAOI was associated with a 
significantly higher risk of death (0.81% vs 0.05%; 
p<0.001) and overnight hospital readmission (15.7% vs 
7.1%; p<0.001) in the first year of life.
Conclusions A composite NAOI can be derived from 
English hospital administrative data. This E-NAOI 
demonstrates good concurrent and predictive validity in 
the first year of life. It is a cost-effective way to monitor 
neonatal outcomes.
InTrODuCTIOn
Access to information on adverse neonatal outcomes 
is important for various purposes including moni-
toring the safety of obstetric care, gauging demand 
for specialist neonatal, paediatric and commu-
nity services, and providing contextual material 
for the design of research studies or public health 
interventions.
The Apgar score is one method for assessing the 
condition of the newborn infant immediately after 
birth, and a low Apgar score at 5 min has been 
shown to be associated with an increased risk of 
neonatal and infant death, particularly for term 
infants.1 However, while the Apgar score is a useful 
method to report on the status of a newborn, it does 
not directly record or predict longer term morbidity 
and is a weaker predictor of outcome for preterm 
infants. Some commentators have also expressed 
concerns that the score is not weighted to reflect the 
relative importance of some of the components.2
At a national level, it is possible to monitor popu-
lation rates of neonatal mortality3 and individual 
morbidities, such as seizures or intraventricular 
haemorrhage. However, these events are too rare 
to be used at a local level to monitor quality of 
care and detect significant changes over time as the 
signal to noise ratio is too low.4 Within well-funded 
randomised controlled trials and observational 
What is already known on this topic?
 ► In high-income countries, severe neonatal 
morbidity has been suggested as a more 
relevant outcome than perinatal mortality 
for monitoring the safety of obstetric care 
and gauging demand for specialist neonatal, 
paediatric and community services.
 ► A composite neonatal adverse outcome 
indicator (NAOI) derived from routine hospital 
data offers several potential advantages 
over bespoke data collection on individual 
morbidities.
 ► These issues motivated the development of 
a composite NAOI using routinely collected 
Australian hospital administrative data. It is 
unknown whether this indicator can be used in 
other countries.
What this study adds?
 ► This study translated the Australian NAOI for 
use with routinely collected English hospital 
data. It was necessary to modify the Australian 
NAOI to address potential data quality issues, 
as well as to reflect current neonatal health 
concerns in England.
 ► The resulting English version of the NAOI (the 
E-NAOI) demonstrated good concurrent validity 
as a population measure of severe neonatal 
adverse outcome and was predictive of death 
and hospital admission in the first year of life.
 ► The E-NAOI is a way of monitoring the 
incidence of adverse neonatal outcomes across 
hospitals using routinely collected data. Our 
results suggest the approach could be applied 
in other countries with similar routine hospital 
administrative datasets.
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studies,5–7 it has proven possible to describe rates of adverse 
outcomes by creating a composite neonatal outcome indicator, 
but these require bespoke data collection mechanisms that are 
generally only possible to achieve on a small scale and for a 
limited time period.
These issues motivated Lain et al to develop a composite 
neonatal adverse outcome indicator (the NAOI) using routinely 
collected Australian hospital administrative data.8 The develop-
ment of the indicator followed an iterative process including a 
literature review, calculation of the incidence of each compo-
nent and its association with hospital readmission and expert 
consensus. It was constructed using the Australian-modified 
version of International Statistical Classification of Diseases, 
10th Revision (ICD-10) diagnosis and procedure codes and was 
found to describe rates of adverse events that were comparable 
with research studies. It also had the advantage of being relatively 
low cost compared with conducting primary data collection.9
As the Australian NAOI was derived using the ICD-10 clas-
sification, it has the potential to be applied to the population 
of newborns in other countries. We evaluated the feasibility of 
translating the Australian NAOI for use with routinely collected 
English hospital neonatal data. The study determined what 
modifications to the NAOI were required to address potential 
data quality issues as well as known neonatal health concerns 
in England. Finally, we examined the validity of the resulting 
English-version NAOI (E-NAOI) in terms of it producing: (1) 
expected rates of adverse events and (2) expected associations 
with death and hospital admission in the first year of life.
MeThODs
Data sources
The study used the Hospital Episode Statistics (HES) database to 
identify births in English National Health Service (NHS) trusts 
(acute hospital organisations) and inpatient episodes up to a year 
after birth. The HES database contains patient demographics, 
diagnostic and procedure information, and administrative data 
for each inpatient episode of care.10 Diagnostic information is 
coded using the ICD-1011 and operative procedures are coded 
using the UK Office for Population Censuses and Surveys Classi-
fication, Fourth Revision (OPCS4).12
The HES database contains supplementary fields (the ‘baby 
tail’) for episodes related to the birth of a baby, which enable 
the capture of details such as birth weight and gestational age. 
Babies’ birth episodes were identified by the presence of ICD-10 
codes Z37-Z38, HRG codes N01-N05 (neonates) or HES fields 
relating to episode type, method of admission, age at start of 
episode and level of neonatal care. The level of data complete-
ness within the ‘baby tail’ varies across NHS trusts but, in 2015, 
data on gestational age and birth weight were available in 90% 
of all birth episodes.13
In HES, each patient is assigned a unique identifier (the 
HESID) that makes it possible to link different events experi-
enced by individual and thereby enables researchers to study 
longitudinal patterns of care, such as rates of unplanned read-
mission following a particular procedure, as well as enabling the 
tracking of patients between hospitals.
study population
We included all liveborn infants from 24 weeks to 43 weeks of 
gestation born between 1 April 2014 and 31 March 2015. This 
time period was chosen to allow follow-up for 1 year after birth 
in the HES database. We excluded NHS trusts with less than 
500 births during the time period (11 of 148 organisations). We 
also removed records that were missing gestational age or birth 
weight (64 084 of 601 713 records) or that had an implausible 
birth weight for gestational age, defined as above the 99.999th 
or below the 0.0001th centile (470 of 537 629 records). Finally, 
we performed data quality assessments at the individual trust 
level and excluded trusts with suspected poor-quality data for 
key data items (online supplementary text S1). This reduced the 
dataset to 484 007 liveborn infants in 114 trusts.
To obtain data on maternal demographic characteristics, the 
babies’ records were linked to the hospital delivery records of 
their mothers using probabilistic linkage that took advantage 
of the fact that information in the baby record was repeated in 
the maternal record (eg, birth weight and gestational age). This 
method is described elsewhere.14 Where missing information in 
the baby’s record was available in the mother’s record (eg, birth 
weight or gestational age), the value was taken from the mother’s 
record. The baby records were further linked to the Office for 
National Statistics death register to allow an assessment of infant 
mortality after hospital discharge within the first year of life. The 
composite was constructed as a binary outcome, in which infants 
were positively identified according to the presence of one or 
more of the E-NAOI components.
Translation of Australian nAOI
The Australian NAOI contained 15 neonatal diagnoses and 
7 procedures. The rationale for the inclusion of specific 
box 1 Adaptations made to the english-version 
neonatal adverse outcome indicator (e-nAOI)
Adaptations to overcome potential data quality issues
 ► Based on the observation that the rate of neonatal blood 
transfusion recorded in Hospital Episode Statistics (HES) 
was implausibly low at all gestations, we did not consider 
the coding of transfusion to be reliable in HES. Others have 
reached similar conclusions when examining the coding of 
obstetric blood transfusions in HES.26
 ► The coding for sepsis was amended to include codes P36.0 to 
P36.8 but to exclude code P36.9 (unspecified bacterial sepsis 
of the newborn) due to concerns that P36.9 is overused to 
record suspected rather than confirmed sepsis. Without this 
exclusion, rates of neonatal sepsis reported in HES were 
implausibly high at 2.6%. With the exclusion, the rates 
observed are in line with the published literature.23
Adaptations to reflect current neonatal health concerns in 
england
 ► Intraventricular haemorrhage (IVH) was restricted to grades 3 
and 4 since grade 2 IVH is of less prognostic significance.27
 ► Respiratory distress syndrome was expanded to include all 
chronic respiratory disease originating in the perinatal period 
as a relevant diagnosis indicating serious adverse outcome.28
 ► Therapeutic hypothermia was included as a relevant 
procedure indicating serious adverse outcome. The use of this 
therapy to treat perinatal asphyxial encephalopathy has been 
increasing in the UK since the publication of the TOBY trial 
in 2008.29 Its use indicates serious concern about the clinical 
condition of the baby at birth.
 ► Bacterial meningitis was included as a relevant diagnosis 
with prognostic significance at least as relevant as that 
of generalised bacterial sepsis. It is associated with both 
short-term mortality and long-term neurodevelopmental 
complications.24
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components is described in detail by Lain et al.8 We constructed 
a list of the ICD-10 diagnosis and OPCS procedure codes used to 
define the individual morbid events that were equivalent to the 
original Australian NAOI codes. The ICD-10-AM (Australian 
Modification) list of diagnoses mapped directly to the standard 
ICD-10 version. The list of Australian ICD-10-AM procedure 
codes were translated into OPCS codes by an expert neonatal 
clinician (SJO).
We identified individual adverse events before inpatient 
discharge after birth. We defined the first hospital inpatient 
stay to include all episodes of care within the birth admission 
plus any inpatient stay resulting from transfer to another NHS 
hospital if that admission started the same or following day after 
discharge from the birth hospital.
To investigate concurrent validity, the incidence of each 
element of the E-NAOI in the HES database was compared with 
the incidence reported by Lain et al8 for the Australian NAOI 
as well as to incidence figures in published population-based 
studies from high-income countries, where available. We used 
an iterative process based on the comparative data available and 
expert clinical input to decide which of the original components 
should be included in the E-NAOI. Before excluding any indi-
vidual morbid conditions with apparently poor ascertainment in 
the HES data, we considered whether alternative codes could 
be used to identify these babies. The list of morbid conditions 
was reviewed by expert clinicians (SJO and HKA) to ensure that 
current neonatal health concerns in England identifiable in HES 
were captured. Amendments to the original NAOI are described 
in box 1.
statistical analysis
To investigate predictive validity, the rates of hospital readmis-
sion and infant death within the first year were calculated for 
babies discharged home alive from the birth episode. χ2 tests 
were used to compare the differences in each of these rates 
between infants identified by the E-NAOI as having morbidity 
compared with infants without any events.
We used multivariate logistic regression models to estimate the 
crude and adjusted effect of maternal and infant characteristics 
on the rate of the E-NAOI. We adjusted for maternal age (<20, 
20–34 and ≥35), parity (primiparous or multiparous), infant 
sex, multiplicity and preterm birth (<37 or ≥37 weeks).
To examine between-trust variation in the adjusted E-NAOI, 
predicted rates were calculated by summing the individual prob-
abilities of an adverse event for all women who delivered at the 
same NHS trust. Risk-adjusted rates were produced for each 
NHS trust by dividing the trust’s unadjusted rate by its predicted 
rate and multiplying this ratio by the national mean.
Funnel plots were used to examine the variation in the adjusted 
E-NAOI values between trusts. These plots ‘test’ whether the 
rate of an NHS trust differs from the national rate for England 
by more than would be expected from chance alone. Assuming 
that differences are due to random (sampling) errors, the chance 
of an organisation being within the limits is 95% for the inner 
funnel and 99.8% for the outer funnel.
All analyses were performed in STATA V.15.0.
resulTs
The initial mother–baby linked dataset contained 603 315 live 
births, which corresponds to 91% of the estimated 662 222 
live births in England during the time period.15 Application 
of the data quality checks and study inclusion criteria reduced 
the dataset to 484 007 liveborn infants between 24 weeks and 
43 weeks of gestation in 114 NHS trusts (figure 1). Excluded 
records had broadly similar demographic characteristics but 
were slightly more likely to relate to older, primiparous mothers 
and to preterm births (online supplementary table S2).
For most of the 15 conditions and procedures within the 
composite NAOI, there was a straightforward way to translate 
the Australian codes into English equivalents. The adjustments 
Figure 1 Data flow diagram.
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Table 1 Incidence (per 100 births) for conditions and procedures indicative of neonatal morbidity
Component
Incidence before first hospital discharge in 
hes (%), by gestational age group*
Incidence before first hospital discharge (%) 
reported by lain et al8 by gestational age group
Decision to include in
e-nAOI
24–33 weeks
(n=8280)
34–36 weeks
(n=25 272)
37–43 weeks
(n=4 50 455)
24–33 weeks
(n=9352)
34–36 weeks 
(n=24 934) 
37–43 weeks 
(n=4 82 489) 
Diagnosis
  Birth weight <1500 g 44.18 0.85 0.01 43.74 0.93 0.01 Included – comparable with Lain 
et al.8
  Gestational age <32 completed 
weeks
51.93 N/A N/A N/A Included – comparable with 
published incidence.15
  Neonatal death within 28 days 
(includes deaths after 28 days if the 
infant was never discharged home)
5.40 0.41 0.07 7.49 0.47 0.07 Included - comparable with 
Lain et al and published UK 
incidence.3 8
  Respiratory distress syndrome 55.74 8.80 0.62 49.04 7.64 0.51 Included – comparable with Lain 
et al.8
  Seizure 0.99 0.25 0.14 1.47 0.39 0.16 Included – comparable with 
Lain et al and published UK 
incidence.8 21
  Intraventricular haemorrhage 
(grades 3 and 4)
2.19 0.02 0.00 2.65 0.05 0.00 Included – comparable with Lain 
et al.8
  Cerebral infarction 0.13 0.02 0.01 N/A Included – comparable with 
published UK incidence.21
  Periventricular leukomalacia 0.75 0.01 0.00 N/A Included – comparable with 
published UK incidence.21
  Birth trauma (intracranial 
haemorrhage paralysis due to 
brachial plexus injury, skull or long 
bone fracture)
0.25 0.09 0.07 0.33 0.08 0.09 Included – comparable with Lain 
et al.8
  Hypoxic ischaemic encephalopathy 1.23 0.34 0.19 0.39 0.17 0.07 Included – comparable with 
published UK incidence.21 22
  Necrotising enterocolitis 5.36 0.20 0.01 2.93 0.14 0.01 Included – comparable with Lain 
et al.8
  Bronchopulmonary dysplasia 7.87 0.03 0.00 6.08 0.03 0.00 Excluded – a wider category 
capturing all chronic respiratory 
disease included instead.
  Sepsis/septicaemia (Streptococcus 
Staphylococcus, Escherichia coli, 
unspecified Gram negative)
10.08 0.90 0.21 10.88 1.52 0.30 Included - comparable with Lain 
and published UK incidence.8 23
  Pneumonia 2.45 0.56 0.18 2.15 0.36 0.11 Included – comparable with 
Lain.8
  Other respiratory (primary 
atelectasis and respiratory failure)
2.36 0.21 0.08 N/A Included.
  Chronic respiratory disease 
originating in the perinatal period
13.89 0.07 0.01 N/A Newly added diagnosis.
  Bacterial meningitis 0.74 0.09 0.04 N/A Newly added diagnosis – 
comparable with published UK 
incidence.24
Procedure
  Resuscitation (intubation and/or 
chest compression)
14.87 1.05 0.30 21.11 1.54 0.47 Included – comparable with Lain 
et al.8
  Ventilatory support (mechanical 
ventilation/CPAP/high flow nasal 
cannulae)
70.52 13.99 1.82 57.03 7.13 0.66 Included – higher than Lain et al 
but not implausible.
  Central venous or arterial catheter 30.62 2.45 0.35 34.12 3.83 0.34 Included – comparable with Lain 
et al.8
  Pneumothorax requiring intercostal 
catheter
3.57 0.67 0.18 1.87 0.33 0.04 Included – higher than Lain et al 
but not implausible.
  Any intravenous fluids 2.08 1.35 0.29 46.64 8.87 0.95 Included – lower than Lain et al. 
Suggests undercoding.
  Transfusion of blood or blood 
products
0.47 0.11 0.02 18.08 0.86 0.10 Excluded – Much lower than Lain 
et al and published literature.
  Any body cavity surgical procedure 7.93 1.49 0.24 4.56 1.01 0.19 Included – comparable with Lain 
et al.8
  Therapeutic hypothermia 0.02 0.24 0.10 N/A Newly added procedure – 
comparable with published UK 
incidence.25
Continued
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to construction of the NAOI to address potential data quality 
issues in HES and current neonatal health concerns in England 
are described in box 1.
Among the 484 007 liveborn infants in the analysis, 5.4% had 
one or more of the E-NAOI conditions or procedures recorded 
before their first hospital discharge. Table 1 gives the frequency 
of the E-NAOI and of each E-NAOI component condition for 
early preterm (<34 weeks), late preterm (34–36 weeks) and 
term births (≥37 weeks). E-NAOI incidence was much higher 
in the early preterm births (84.6%) compared with late preterm 
(20.1%) and term births (3.1%), partly because all infants less 
than 32 weeks’ gestation are included in the NAOI and comprise 
72% of the early preterm group.
The most common conditions among infants of all gestational 
ages were ventilatory support (mechanical ventilation and/or 
continuous positive airway pressure (CPAP) or high flow nasal 
cannulae) and respiratory distress syndrome, which themselves 
were highly correlated (76% of infants with respiratory distress 
syndrome required ventilatory support). For most components, 
the incidence measured in the English NHS was comparable 
with the incidence reported in the original Australian study. 
Notable differences between the English and Australian figures 
are described in table 1.
Assessment of validity
The proportion of infants identified as having one or more of 
the conditions in the E-NAOI fell from 77.2% at 32 weeks of 
gestation to 2.4% at 39 weeks of gestation but increased to 4.3% 
at 42 weeks (figure 2). The overall pattern of adverse events by 
week of gestation is consistent with expectations and similar to 
that described by Lain et al.8 Patterns of E-NAOI incidence also 
varied by mode of birth according to expectations, with higher 
rates observed among babies born by emergency compared with 
elective caesarean section.
The distribution of maternal and infant characteristics strat-
ified by whether an infant had an E-NAOI event is shown in 
table 2. Primiparity, maternal age over 34 year, male infant sex, 
multiple and preterm birth were associated with increased risk of 
being identified by the E-NAOI (table 2).
Among babies discharged home alive, the E-NAOI was strongly 
associated with the risk of death following discharge home and 
with hospital readmission. Infants identified by the E-NAOI 
were over twice as likely to be admitted to hospital overnight 
in their first year of life (15.7% vs 7.1%; p<0.001) and over 15 
times more likely to die within a year of birth (0.81% vs 0.05%; 
p<0.001) than infants not identified by the NAOI. Similar find-
ings were observed when these rates were calculated for term 
infants only (table 3).
The adjusted proportion of neonates identified with an 
E-NAOI condition varied from 2% to 11% between NHS trusts 
of birth. There was a slightly higher mean rate observed among 
NHS trusts with a neonatal intensive care unit (5.5%) compared 
with those with a local neonatal unit (5.4%) and special care 
baby unit (5.3%), but this difference was small compared with 
the differences between organisations (figure 3).
DIsCussIOn
Main findings
Using routine hospital data in England from April 2014 to 
March 2015, we were able to adapt the Australian NAOI to 
produce a similar composite indicator for measuring severe 
adverse neonatal outcomes within NHS trusts. The resulting 
E-NAOI included 23 components (16 diagnoses and 7 proce-
dures). The selection of individual components was driven by 
the quality of the routine hospital data as well as known neonatal 
health concerns in England. This necessitated a number of 
adaptations to the original composite measure developed using 
routine Australian hospital data, but these changes were rela-
tively minor. For instance, one of the changes was the exclusion 
of neonatal blood transfusion as a component procedure. Lain 
et al8 reported the use of transfusion in 18.08% of early preterm 
infants but only 0.10% of term infants; therefore, the overall 
impact of not including this procedure in the E-NAOI is likely to 
be small. Nonetheless, the weaknesses in data quality identified 
by this work deserve to be addressed by NHS trusts, and there 
are various ways in which trusts could verify data quality. For 
example, blood transfusion is recorded in the National Neonatal 
Research Database (NNRD) database, and trusts could use this 
to ensure it is correctly coded within HES.
The resulting E-NAOI demonstrated good concurrent 
validity. First, the incidence of the individual components of the 
composite indicator as measured in the English data were often 
consistent with the incidence reported in Australia. They were 
Component
Incidence before first hospital discharge in 
hes (%), by gestational age group*
Incidence before first hospital discharge (%) 
reported by lain et al8 by gestational age group
Decision to include in
e-nAOI
24–33 weeks
(n=8280)
34–36 weeks
(n=25 272)
37–43 weeks
(n=4 50 455)
24–33 weeks
(n=9352)
34–36 weeks 
(n=24 934) 
37–43 weeks 
(n=4 82 489) 
Composite
  Any diagnoses or procedure 84.57 20.13 3.10 81.88 18.32 2.40
*Gestational age categories were selected to allow comparison with the figures reported by Lain et al.
CPAP, continuous positive airway pressure; E-NAOI, English-version neonatal adverse outcome indicator; HES, Hospital Episode Statistics.
Table 1 Continued 
Figure 2 Rate of neonatal morbidity by gestational age at birth 
identified by the E-NAOI. Note: gestational age <32 completed weeks is 
a component of the E-NAOI. E-NAOI, English-version neonatal adverse 
outcome indicator.
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also similar to figures published by population-based studies 
in other high-income countries, where reported. Second, the 
incidence of events decreases by gestational age until term, in 
line with expectations. Third, the E-NAOI demonstrated good 
predictive ability, as indicated by a two-fold increased risk of 
overnight hospital admission and a 15-fold increased risk of 
death within the first year among infants flagged by the E-NAOI 
at birth. Although neither hospital readmission nor infant death 
Table 2 Association of E-NAOI with maternal and infant characteristics
risk factor no. of infants (%)
no. infants with 
e-nAOI event e-nAOI rate (%)
Adjusted relative risk (rr)* of e-nAOI 
among births with this characteristic 
(95% CI)
Maternal characteristics
  Age: <20 years 17 928 3.71 1064 5.93 0.96 (0.89 to 1.02)
  Age: 20–34 years 3 67 164 75.88 19 119 5.21 Reference
  Age: ≥35 years 98 757 20.41 5877 5.95 1.09 (1.05 to 1.13)
  Primiparous 1 76 472 36.46 10 860 6.16 1.29 (1.25 to 1.32)
  Multiparous 3 07 535 63.54 15 200 4.94 Reference
Infant characteristics
  Female 2 35 702 48.70 10 991 4.66 Reference
  Male 2 48 242 51.30 15 068 6.07 1.32 (1.28 to 1.35)
  Term 4 50 454 93.07 13 978 3.10 Reference
  Preterm 33 553 6.93 12 091 36.04 17.54 (17.06 to 18.04)
  Multiple 13 399 2.77 3008 22.45 1.14 (1.08 to 1.19)
*Adjusted for maternal age, parity, infant sex, preterm and multiple birth. One hundred and fifty-eight and 63 records were missing maternal age and infant sex, respectively.
E-NAOI, English-version neonatal adverse outcome indicator.
Table 3 Rates of hospital readmission or death among infants discharged home, up to their first birthday, for conditions and procedures 
indicative of neonatal morbidity
e-nAOI component
Any hospital readmission 
in first year (%)
Overnight hospital 
readmission in first year (%)
Death in first 
year (%)
All infants not identified by E-NAOI (n=457 939) 23.16 7.09 0.05
All infants identified by E-NAOI (n=26 068) 36.80 15.69 0.81
Term infants not identified by E-NAOI (n=436 477) 22.65 6.79 0.05
Term infants identified by E-NAOI (n=13 978) 30.17 11.59 0.92
Individual E-NAOI components*
  Birth weight <1500 g 55.41 28.30 0.87
  Gestational age <32 weeks 54.54 27.22 0.78
  Respiratory distress syndrome 42.01 18.14 0.56
  Seizure 47.60 19.80 2.33
  Intraventricular haemorrhage (grades 3 and 4) 65.22 30.43 1.45
  Cerebral infarction 46.97 12.12 N/A
  Periventricular leukomalacia 64.91 28.07 N/A
  Birth trauma (intracranial haemorrhage paralysis due to brachial plexus injury, skull or 
long bone fracture)
29.62 11.41 N/A
  Hypoxic ischaemic encephalopathy 38.63 14.51 1.60
  Necrotising enterocolitis 66.86 39.21 1.54
  Sepsis/septicaemia (Streptococcus, Staphylococcus, Escherichia coli, unspecified Gram 
negative)
45.82 22.81 1.02
  Pneumonia 39.44 17.40 1.00
  Other respiratory (primary atelectasis and respiratory failure) 42.41 18.15 0.74
  Chronic respiratory disease originating in the perinatal period 68.14 38.34 1.89
  Bacterial meningitis 36.80 15.24 0.74
  Resuscitation 41.84 19.73 1.01
  Ventilatory support (mechanical ventilation and/or CPAP) 38.63 16.79 0.57
  Central venous or arterial catheter 51.74 26.14 1.27
  Pneumothorax requiring intercostal catheter 39.67 17.70 0.61
  Any intravenous fluids 26.66 10.46 0.17
  Any body cavity surgical procedure 63.48 40.14 1.63
  Therapeutic hypothermia 36.40 13.70 1.50
* See online supplementary table S1 for overall incidence.
CPAP, continuous positive airway pressure; E-NAOI, English-version neonatal adverse outcome indicator.
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are perfect measures to validate the indicator, they have been 
widely used as proxies for longer term neonatal morbidity.16 17
Caution should also be used when extrapolating the E-NAOI 
to estimate longer term morbidity, as the E-NAOI represents 
morbidity in the neonatal period only. Some conditions such as 
birth trauma (primarily localised paralysis due to brachial plexus 
injury) are usually resolved without readmission, whereas others 
are likely to have implications beyond the immediate neonatal 
period.
The reasonable level of validity demonstrated in this initial 
study suggests that further evaluation of the value of the 
composite as a performance indicator is warranted. A particular 
focus could be whether the performance of the overall E-NAOI 
could be improved when used for specific purposes. For example, 
although we found evidence of significant variation between 
trusts in the adjusted rate of the E-NAOI, we speculate that when 
used for local quality improvement, a version that only included 
amenable conditions may give different results. Decisions about 
which conditions are amenable to improvement are conceptually 
challenging. For example, different commentators may disagree 
about the extent to which low birth weight and preterm birth 
are preventable through best practice. The relative merits of this 
approach are not addressed in the present study and would be 
more thoroughly investigated in conjunction with a local quality 
improvement initiative. We recommend further consensus and 
validation work in this area.
strengths and limitations of the study
The study has several methodological strengths. The dataset 
is large and drawn from a linked, population-based dataset. 
Furthermore, the linkage with mortality data and hospital 
admission episodes after birth allowed the predictive validity of 
the composite measure to be evaluated. The indicator can be 
calculated using administrative hospital data, secondary access to 
which is associated increasingly short time lags of 2–3 months.18 
It is therefore a cheap and timely method of monitoring the inci-
dence of adverse neonatal outcomes in comparison with bespoke 
data collection methods.
Some commentators have questioned the accuracy with 
which hospital administrative data captures individual neonatal 
morbidities, with particular concern about under-reporting.19 
However, the E-NAOI includes both procedures and diagnoses 
and is therefore less susceptible to underascertainment of indi-
vidual morbid events because: (A) severely ill neonates may have 
several different diagnoses and require multiple procedures, (B) 
procedures are more reliably reported than diagnoses and (C) the 
more severe the condition, the more likely it is to be reported.20
Although a composite measure has many advantages, a limita-
tion of this study is the need to create dichotomous categories 
to represent severe neonatal morbidity out of what is in reality a 
spectrum of morbidity. For instance, mechanical ventilation and 
CPAP were included, but the relatively more common procedure 
of oxygen supplementation is not recognised.
A second limitation is the between-trust variation in use of 
procedures (and therefore E-NAOI incidence) due to availability 
of services and differences in practice, making it difficult to 
attach significance to differences between providers. In addition, 
despite our data quality checks, we cannot rule out the possi-
bility of differences in local coding practices or definitions of 
particular procedures or diagnoses.
Finally, we dropped a number of records because of poor 
data quality. Although the excluded records shared broadly 
similar characteristics to the included records (online 
supplementary table S2), improvements in data quality at 
the minority of organisations with poor quality data are 
required before the E-NAOI is useful for giving a ‘state of 
the nation’ assessment for England.
In summary, the composite E-NAOI is a standardised 
method of monitoring adverse neonatal outcome across 
maternity units that demonstrates reasonable concurrent 
and predictive validity and could be applied in other coun-
tries with hospital administrative datasets with comparable 
diagnosis (ICD-10) and procedure codes. The indicator has 
the potential to be used for national surveillance, supporting 
policy development and evaluation as well as clinical audit 
and research. It could be further validated and refined 
through linkage with the NNRD that contains neonatal elec-
tronic patient records from all NHS neonatal units.
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